Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Jan. 31, 2019
Jan. 31, 2018
Revenues $ 19,327 $ 26,152 $ 40,587 $ 53,028
Operating costs and expenses:        
Cost of Revenues 14,748 15,607 28,987 31,038
Research and development 833 812 1,561 1,559
Selling, general and administrative 11,497 11,049 22,467 21,954
Legal fee expense 1,142 1,700 2,443 2,131
Total operating costs and expenses 28,220 29,168 55,458 56,682
Operating loss (8,893) (3,016) (14,871) (3,654)
Other income (expense):        
Interest 227 185 501 342
Other 132 33 179 69
Foreign exchange gain (loss) 126 800 (198) 605
Loss before income taxes (8,408) (1,998) (14,389) (2,638)
Benefit for income taxes 1,097   1,097
Net loss $ (8,408) $ (901) $ (14,389) $ (1,541)
Net loss per common share:        
Basic and diluted (in Dollars per share) $ (0.18) $ (0.02) $ (0.30) $ (0.03)
Weighted average common shares outstanding:        
Basic and diluted (in Shares) 47,199 46,941 47,197 46,806